Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001520262-26-000110

EVP R&D, Chief Medical Officer sold 9,000 shares at $48.58 ($437,220)

  • EVP R&D, Chief Medical Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-03 Exercise or conversion : show line 1 in the form 10b5-1 +104 $19.34 $2,011 73,493 D
2026-08-03 Exercise or conversion : show line 2 in the form 10b5-1 +4,896 $24.59 $120,393 78,389 D
2026-08-03 Sale : show line 3 in the form 10b5-1 −9,000 $48.58 $437,220 69,389 D
Open-market sales · 9,000 sh · avg $48.58 · $437,220

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-08-03 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Buy) −104 1,252 D
2026-08-03 Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (Right to Buy) −4,896 66,276 D
Loading xslF345X06/form4.xml…